WNK2 and prostate cancer: We detected GLP-1R expression in human prostate cancer tissue and prostate cancer cell lines, and Ex–4 attenuated prostate cancer growth both in vitro and in vivo via inhibition of extracellular signal-regulated kinase-mitogen-activated protein kinase (ERK-MAPK) activation, leading to inhibition of cell proliferation [8].